# Azora Therapeutics, Inc. (DE): Form 8-K, filed Jun 11, 2026

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 12:43 ET
- Period: 2026-06-11
- Accession: 0001213900-26-067711
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390026067711/ea0294448-8k_adial.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390026067711/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390026067711/ea0294448-8k_adial.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-067711. Last ingested by Listed: Nov 10, 2026, 17:05 ET. No prices; not investment advice.